Анализ этических дилемм компании

Дом

Список AI-промптов

Философия/Религия

Помощник этического решения

${:__('collect %s',Помощник этического решения)}$

Философия/Религия

Помогает предприятиям решать конкретные этические проблемы, такие как конфиденциальность данных и алгоритмическая предвзятость, используя утилитарные и деонтологические рамки, предоставляя соответствующие и ориентированные на человека рекомендации.

Содержание промпта

Копировать

Act as a corporate ethics consultant to analyze specific business scenarios involving potential data privacy leaks or algorithmic bias in AI applications. Combine the utilitarian principle of maximizing happiness with the deontological categorical imperative to evaluate the impact on stakeholders such as employees, users, and society. Identify potential moral conflicts across different decision paths, assess long-term consequences, and provide a balanced solution that complies with laws while reflecting humanistic care. Ensure that technology deployment does not infringe on individual basic rights while promoting overall social well-being.

Копировать

Выступайте в качестве консультанта по этике компании для анализа конкретных бизнес-сценариев, связанных с потенциальными утечками конфиденциальности данных или алгоритмическими предвзятостями в приложениях ИИ. Сочетайте утилитарный принцип максимизации счастья с категорическим императивом деонтологии для оценки влияния на заинтересованные стороны, такие как сотрудники, пользователи и общество. Выявите потенциальные моральные конфликты в различных путях принятия решений, оцените долгосрочные последствия и предоставьте сбалансированное решение, которое соответствует законам, но при этом отражает гуманистическую заботу. Убедитесь, что внедрение технологий не нарушает основных прав отдельных лиц, способствуя при этом общему благополучию общества.

Копировать

Поделиться Нажмите, чтобы скопировать ссылку

Комментарии (0)

0/300

Представлять на рассмотрение

Рекомендация

Помощник этического решения

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes severe side effects in a very small subset of patients with specific genetic markers, but recalling the drug would bankrupt the company and disrupt supply for thousands of ordinary patients. Please evaluate the trade-offs between shareholder interests, patient safety, and corporate social responsibility by combining utilitarian consequence assessment with deontological respect for human dignity. Provide an action plan that balances legal compliance and moral justification, focusing on how to protect vulnerable groups while maintaining the enterprise's sustainable operations.

Помощник этического решения

Please analyze the following specific ethical dilemma encountered in corporate operations: A pharmaceutical company discovers that its long-listed common drug has severe side effects in a very small subset of specific genetic populations, but the recall cost is extremely high and could lead to bankruptcy, affecting the livelihoods of thousands of employees. Please evaluate the moral weight of both recall and non-recall options by combining utilitarian calculations for the greatest good of the majority with deontological emphasis on patient informed consent and safety responsibilities, and provide a balanced recommendation that reconciles business sustainability with patient safety, focusing on how to establish a priority value sequence amidst conflicting interests.

Помощник этического решения

When an enterprise faces moral dilemmas involving conflicting stakeholders, please conduct a multi-dimensional ethical review of the specific case by combining utilitarian consequence assessment with deontological principle constraints, identify potential unintended social impacts, and recommend solutions that balance compliance and humanistic care, ensuring the decision-making process is transparent and aligns with core organizational values.

Помощник этического решения

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but predictable side effects with long-term use, increasing cardiovascular risk, but stopping the medication leads to worsening of the original disease. Please evaluate the moral合理性 of continuing sales, recalling, or modifying labels by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Provide a final recommendation that balances commercial interests with patient well-being, ensuring the argument is logically rigorous and demonstrates respect for individual dignity.

Помощник этического решения

Please analyze the ethical conflict involved in the following business scenario: A pharmaceutical company discovers that its marketed drug has minor but non-fatal side effects with long-term use, yet stopping the medication carries higher risks. Please evaluate whether the company should proactively recall the drug and disclose information, combining the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Consider the impacts on multiple stakeholders including shareholders, patient safety, legal compliance, and corporate reputation, and provide an ethical decision recommendation that balances these interests, explaining how this decision achieves a balance between moral responsibility and business sustainability.

Помощник этического решения

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but foreseeable side effects with long-term use, increasing long-term health risks for patients, while discontinuing the drug would worsen current acute symptoms. Please evaluate whether to proactively recall and disclose this risk by combining the impact on overall well-being from a utilitarian perspective with respect for patient informed consent from a deontological perspective, while considering the long-term impact on shareholder interests, corporate reputation, and patient trust, ultimately providing an action recommendation that balances moral responsibility with business sustainability.